Close Menu
    What's Hot

    Delcam Retirement Benefits Scheme Completes Bulk Purchase Annuity Transaction With Royal London

    November 5, 2026

    JAB Insurance completes acquisition of Utmost Life and Pensions

    October 29, 2026
    Milliman

    Competitive US Pension Risk Transfer Cost Decreases During September

    October 28, 2026
    X (Twitter) LinkedIn
    Longevity & Mortality Investor
    • Home
    • Coverage
      1. Life Insurance Capital Solutions
      2. Life Insurance
      3. Longevity and Mortality Risk Transfer
      4. Mortality
      5. Secondary Life Markets
      6. View All

      Symetra and TIAA Partner To Launch Mariner Re

      October 27, 2026

      Chariot Re Announces Fourth Reinsurance Transaction, First Covering Japanese Liabilities

      October 15, 2026

      Pacific Life Re Executes First Asset-Intensive Reinsurance Transaction in Hong Kong

      September 9, 2026

      Bermuda Life & Annuity Sidecar Market Quadruples as Alternative Asset Manager/Life Insurance Convergence Continues

      September 9, 2026

      Q&A: Alexandr Dudarev, CEO, Inshurik

      October 28, 2026

      Is Dementia the Next Big Longevity Event?

      October 15, 2026

      US Individual Life Insurance Sales Continue Growth Trend in the Second Quarter

      August 13, 2026

      Shaping the Future of Health Insurance Through Innovation and Analytics

      June 10, 2026

      Delcam Retirement Benefits Scheme Completes Bulk Purchase Annuity Transaction With Royal London

      November 5, 2026

      JAB Insurance completes acquisition of Utmost Life and Pensions

      October 29, 2026
      Milliman

      Competitive US Pension Risk Transfer Cost Decreases During September

      October 28, 2026

      New Report Highlights Tighter Regulatory Oversight of Asset-Intensive Reinsurance

      October 28, 2026

      Record Low Mortality Rates So Far in 2026 in England and Wales, Says CMI

      October 12, 2026

      Record Low Mortality Rates So Far in England and Wales in 2026

      July 9, 2026

      Organ Transplant Improvements Test Life Expectancy Assessment Models

      July 8, 2026

      The Pursuit of Everlasting Life Unlikely to Shift Actuarial Models

      June 10, 2026

      UK Equity Release Activity Nudges Higher in Third Quarter

      October 28, 2026

      Household Capital Completes New Reverse Mortgage Securitisation

      October 22, 2026

      New Report Suggests Life Settlement Market Poised for Long-Term Expansion

      October 15, 2026

      Further Declines in HECM Endorsements Suggest Urgent Reform is Needed

      October 15, 2026

      Delcam Retirement Benefits Scheme Completes Bulk Purchase Annuity Transaction With Royal London

      November 5, 2026

      JAB Insurance completes acquisition of Utmost Life and Pensions

      October 29, 2026
      Milliman

      Competitive US Pension Risk Transfer Cost Decreases During September

      October 28, 2026

      UK Equity Release Activity Nudges Higher in Third Quarter

      October 28, 2026
    • Events
    • Latest Issues
      Life Risk News Editors Letter

      Editor’s Letter – Volume 2, Issue 10, October 2026

      October 15, 2026

      Editor’s Letter – Volume 2, Issue 9, September 2026

      September 9, 2026

      Editor’s Letter – Volume 2, Issue 8, August 2026

      August 12, 2026

      Editor’s Letter – Volume 2, Issue 7, July 2026

      July 8, 2026

      Editor’s Letter – Volume 2, Issue 6, June 2026

      June 10, 2026
    • Contact Us
    Newsletter
    Longevity & Mortality Investor

    The Structural Decision for Setting Up a Life Settlement Vehicle in Ireland

    Secondary Life Markets September 23, 2026By Greg Winterton
    Share
    Twitter LinkedIn Email

    According to Life Settlement Investor Sentiment 2025, a report published late last year by insurance asset manager, Conning (in conjunction with the European Life Settlement Association (ELSA), publisher of Longevity and Mortality Investor), life settlements are on their way to becoming an established portfolio allocation. 

    There’s plenty in that observation to like for those in the space and plenty of those investment managers out on the capital raising trail looking to tap into this increased interest will be raising money for an Irish-domiciled investment vehicle. 

    There are two main reasons why a life settlement portfolio manager chooses Ireland: first, if they have or want to court US investors, the QIAIF (Qualifying Investor Alternative Investment Fund), housed in the ICAV (Irish Collective Asset-Management Vehicle), is particularly attractive because it can generally be structured to achieve tax treatment that is familiar and efficient from a US federal tax perspective. In addition, overlaying the ICAV in a QIAIF wrapper incorporates the EU’s AIFMD marketing passport, providing asset managers with a structure that straddles a large potential investor base simultaneously. 

    In practice, most life settlement ICAVs targeting institutional capital are authorised as QIAIFs, because unlike many retail fund wrappers such as UCITS, the QIAIF regime can comfortably accommodate portfolios consisting entirely of illiquid assets, including life insurance policies. Add to that the availability of custom drawdown structures, no mandatory diversification/concentration rules, and the all-important 24-hour Central Bank of Ireland authorisation fast-track, and, according to David Naughton, Partner at Byrne Wallace Shields, you get a compelling structuring argument in favour of Ireland as an investment funds domicile. 

    “For international investors, the QIAIF has become a very familiar structure. It combines a highly flexible investment framework with a tax regime that is well understood by institutional allocators. For an asset manager pitching pensions, insurers and family offices, familiarity matters. Investment committees are far more likely to approve a structure they have seen before than an unfamiliar offshore vehicle,” he said. 

    “But for life settlement managers specifically, the 24-hour authorisation really matters. If they identify a $50m portfolio of life insurance policies hitting the market, they might only have a month or so to win the bid and deploy capital. Sometimes, they can’t wait months for regulatory approval for a fund.” 

    The QIAIF is Ireland’s most common regulated route into the life settlement asset class, but not every life settlement strategy is designed for larger institutional investors.  

    Some managers are looking for a vehicle to accumulate policies, finance acquisitions or accommodate a smaller group of investors rather than market a fund across Europe or beyond. For those situations, Ireland offers an ‘unregulated’ option: the Section 110 special purpose company, a structure borrowed from the securitisation market. These vehicles are not regulated by the Central Bank of Ireland but typically are designed to hold assets and issue funding instruments against them, so for life-settlement managers, that distinction opens up a different set of structuring possibilities. 

    Under Ireland’s Section 110 regime, a qualifying special purpose company can hold portfolios of life insurance policies while funding itself through the issuance of debt securities. Those financing costs are generally deductible, meaning the vehicle itself is intended to retain little taxable profit. The structure becomes particularly attractive when combined with Ireland’s quoted Eurobond regime, under which qualifying debt can typically be serviced without Irish withholding tax. The result is a tax-neutral platform that has long been familiar to participants in the securitisation and structured finance markets. 

    “The Section 110 route tends to appeal where the focus is on efficient asset financing, private capital arrangements or a securitisation-style investment model rather than broad-based fund distribution,” said Naughton. 

    While these two options are generally considered ‘either/or’ by life settlement portfolio managers, that doesn’t have to always be the case. A regulated QIAIF may sit at the investor-facing level, with its familiar governance and distribution characteristics, while one or more Section 110 vehicles beneath it hold portfolios of life policies or undertake financing activities. The result is a structure that combines the fundraising advantages of a regulated fund with the flexibility traditionally associated with securitisation vehicles. 

    “Seeing the QIAIF and the Section 110 routes as competing alternatives is arguably a simplification of the options because, while not the most commonly taken path, they can be used in combination with each other,” said Naughton.  

    Another factor frequently cited by practitioners as to why they set up in Ireland – regardless of the vehicle they choose – is Ireland’s common-law legal system. While often overshadowed by tax and regulatory considerations, legal familiarity can matter in cross-border transactions involving life policies, financing arrangements and multiple classes of investors. 

    Not everyone regards the distinction as decisive, of course; Luxembourg, for example, has a civil law system, and is one of Europe’s largest fund domiciles. Indeed, some life settlement vehicles are set up there.  

    But for those that decide that Ireland is where they want their investment vehicle to call home, Naughton says that investors wouldn’t set up there if there wasn’t a support ecosystem to do the middle and back-office work effectively. 

    “Ireland has a deep bench when it comes to the life settlement service provider community. Life settlements are a complex asset class that is not as well-known as other alternative investment strategies. Ireland has administrators, depositaries, securities intermediaries, auditors and legal counsel who know this asset class exceptionally well, and while investors and managers like the tax and legal features and benefits of setting up here, the domain expertise of the broader ecosystem is just as important,” he said. 

    2026 - September Life Settlement Litigation Life Settlements Longevity Risk Volume 2 Issue 10 – October 2026
    Share. Twitter LinkedIn Email

    Related Posts

    New Report Highlights Tighter Regulatory Oversight of Asset-Intensive Reinsurance

    October 28, 2026By Greg Winterton
    Life Risk News Editors Letter

    Editor’s Letter – Volume 2, Issue 10, October 2026

    October 15, 2026By Chris Wells

    New Report Suggests Life Settlement Market Poised for Long-Term Expansion

    October 15, 2026By Greg Winterton

    Is Dementia the Next Big Longevity Event?

    October 15, 2026By Richard Marshall and Scott Hamilton
    Latest Issue

    New Report Suggests Life Settlement Market Poised for Long-Term Expansion

    October 15, 2026

    Is Dementia the Next Big Longevity Event?

    October 15, 2026

    Further Declines in HECM Endorsements Suggest Urgent Reform is Needed

    October 15, 2026
    Litigation

    Litigation Update: U.S. Bank National Association v. Pacific Life Insurance Company

    September 23, 2026
    Ad

    Where Longevity and Mortality Meet the Markets
    ISSN 2978-5219

    X (Twitter) LinkedIn
    Coverage
    • Life Insurance Capital Solutions
    • Life Insurance
    • Longevity and Mortality Risk Transfer
    • Mortality Risk
    • Secondary Life Markets
    More Info
    • Home
    • About Us
    • Contact Us
    • Guest Articles
    • Submit Story Idea
    Our Newsletter
    Get the latest industry news, commentary and events from the Longevity & Mortality Investor directly into your inbox. Why not sign up today?

    © 2026 Longevity & Mortality Investor. Website by Kavells.
    • Sitemap
    • Privacy Policy
    • Copyright Notice
    • Terms & Conditions

    Type above and press Enter to search. Press Esc to cancel.